← Back to Search

MyStroke Educational Platform for Stroke Management

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years old

Receiving outpatient stroke care at the Hospital of the University of Pennsylvania

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

Study Summary

This trial tests if a video-based educational platform helps stroke patients understand their condition and be more satisfied.

Who is the study for?

This trial is for adults who had an ischemic stroke between 1 and 10 years ago, are getting outpatient care at the University of Pennsylvania Hospital, can use a smart device or computer, and are willing to do follow-up surveys. It's not for those who can't use the app, need full-time caregiver help, had their stroke outside the 1-10 year window, or have severe speech difficulties.Check my eligibility

What is being tested?

The MyStroke clinical trial tests a personalized video-based educational platform designed to improve patient satisfaction and knowledge about chronic stroke management. Participants will be randomly assigned to either receive this intervention or not.See study design

What are the potential side effects?

Since MyStroke is an educational tool rather than a medication or medical procedure, it does not have typical side effects. However, users may experience frustration if they find the technology difficult to use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am getting outpatient stroke care at the University of Pennsylvania Hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient satisfaction with stroke education (90 days)

Stroke etiology recognition (90 days)

Stroke risk factor recognition (90 days)

Secondary outcome measures

EuroQOL - visual analog scale (7 days)

EuroQOL - visual analog scale (90 days)

Medication adherence (7 days)

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MyStrokeExperimental Treatment1 Intervention

Access to a personalized video-based stroke educational platform

Group II: Standard EducationActive Control1 Intervention

Standard stroke patient education as per the medical providers

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,882,183 Total Patients Enrolled

29 Trials studying Stroke

2,101 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently open for this investigation?

"Affirmative. Per the details noted on clinicaltrials.gov, this medical experiment commenced recruitment on October 17th 2023 and is actively seeking participants at present. 100 applicants will be accepted from one site in total."

Answered by AI

To what extent is the clinical trial recruiting participants?

"Affirmative. The details available on clinicaltrials.gov demonstrate that the trial, which was first posted on October 17th 2023, is actively seeking participants. Approximately 100 individuals must be recruited from 1 medical centre to complete the study's objective."

Answered by AI

What are the main goals of this experiment?

"The primary goal of this 90-day trial is to assess stroke etiology recognition. Secondary objectives are medication adherence, which encompasses a 3 question survey with scores ranging from 0-36 and higher values indicating increased risk; recognizing vascular risks factors in 7 days; and measuring the same three questions for medication compliance over a similar time frame."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MyStroke in Chronic Stroke

Christopher Favilla 2023. "MyStroke in Chronic Stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06057753.